Supply of Proprietary Genomic Research Kits

The contract involves the procurement and delivery of 20 units of Illumina's Infinium Methylation Screening Array-48 Kit, which is intended for use in an epigenome-wide association study focusing on DNA methylation and its relationship to cardiovascular disease risk. This subcontract falls under the North American Industry Classification System (NAICS) code 325412, which pertains to pharmaceutical preparation manufacturing. The contract was posted by the National Institutes of Health, operating under the Department of Health and Human Services, with a response deadline set for June 18, 2026. This procurement aims to support genomic research by providing specialized proprietary kits crucial for analyzing methylation patterns across the genome. Although specific details about the location of performance and point of contact were not provided, the contract represents an important acquisition to facilitate advanced biomedical research in understanding genetic factors associated with cardiovascular diseases. The solicitation is accessible through the federal contracting portal, indicating transparency and availability for potential subcontractors to participate.